Bonvadis_Instructions

Recent articles

• EU NB issued the EU market approval for Bonvadis® that grants marketing authorization across all 27 EU member states for acute and chronic wounds, and scar management. 2026-03-12
• Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by INVIMA Colombia. 2026-02-22
• The medical device registration application of Bonvadis® for all indications of wounds has been accepted by INVIMA Colombia. 2026-01-31
• Oneness Biotech Highlights Global Strategy at J.P. Morgan Healthcare Conference 2026-01-15
• Bonvadis® topical cream received medical device marketing authorization approval for all indications in wounds by EDA Egypt. 2026-01-05
• Bonvadis® topical cream received medical device import license for all indications in wounds for India. 2025-12-19
• The medical device registration application of Bonvadis® for all indications of wounds has been accepted by Health Canada. 2025-11-11